Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.0190 USD
329.91 M USD
3.71 B USD
9.65 B
About SINO BIOPHARMACEUTICAL
Sector
CEO
S Y Tse
Headquarters
Hong Kong
Website
Founded
2000
FIGI
BBG000NLQVT9
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SBMFF is 0.4113 USD — it has decreased by −3.00% in the past 24 hours. Watch Sino Biopharmaceutical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sino Biopharmaceutical Ltd. stocks are traded under the ticker SBMFF.
SBMFF stock has fallen by −3.00% compared to the previous week, the month change is a −2.63% fall, over the last year Sino Biopharmaceutical Ltd. has showed a −1.06% decrease.
We've gathered analysts' opinions on Sino Biopharmaceutical Ltd. future price: according to them, SBMFF price has a max estimate of 0.88 USD and a min estimate of 0.39 USD. Watch SBMFF chart and read a more detailed Sino Biopharmaceutical Ltd. stock forecast: see what analysts think of Sino Biopharmaceutical Ltd. and suggest that you do with its stocks.
SBMFF reached its all-time high on May 31, 2018 with the price of 2.5350 USD, and its all-time low was 0.2700 USD and was reached on Sep 19, 2011. View more price dynamics on SBMFF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SBMFF stock is 3.09% volatile and has beta coefficient of 1.20. Track Sino Biopharmaceutical Ltd. stock price on the chart and check out the list of the most volatile stocks — is Sino Biopharmaceutical Ltd. there?
Today Sino Biopharmaceutical Ltd. has the market capitalization of 7.60 B, it has decreased by −5.59% over the last week.
Yes, you can track Sino Biopharmaceutical Ltd. financials in yearly and quarterly reports right on TradingView.
Sino Biopharmaceutical Ltd. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
SBMFF earnings for the last half-year are 0.01 USD per share, whereas the estimation was 0.01 USD, resulting in a 9.43% surprise. The estimated earnings for the next half-year are 0.01 USD per share. See more details about Sino Biopharmaceutical Ltd. earnings.
Sino Biopharmaceutical Ltd. revenue for the last half-year amounts to 2.18 B USD, despite the estimated figure of 2.08 B USD. In the next half-year revenue is expected to reach 2.10 B USD.
SBMFF net income for the last half-year is 200.19 M USD, while the previous report showed 148.43 M USD of net income which accounts for 34.87% change. Track more Sino Biopharmaceutical Ltd. financial stats to get the full picture.
Sino Biopharmaceutical Ltd. dividend yield was 1.44% in 2023, and payout ratio reached 35.95%. The year before the numbers were 2.63% and 75.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 25.81 K employees. See our rating of the largest employees — is Sino Biopharmaceutical Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sino Biopharmaceutical Ltd. EBITDA is 974.74 M USD, and current EBITDA margin is 25.87%. See more stats in Sino Biopharmaceutical Ltd. financial statements.
Like other stocks, SBMFF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sino Biopharmaceutical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sino Biopharmaceutical Ltd. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sino Biopharmaceutical Ltd. stock shows the sell signal. See more of Sino Biopharmaceutical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.